ARCHIVES

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 27 No. 42 | November 16, 2001

Download PDF Visit The Full Archive

Related Articles

Cancer Policy: New Cancer Board to Take A Year to Conduct First Study

April 18, 1997

Increase In DCCR Grants May Not Be Possible Without Decreasing Quality, Committee Told

July 28, 1978

Applications Due Sept. 1 For Cancer Prevention Fellows

May 10, 1991

The Future of Cancer Centers: Demographics Informatics, Genetics, Will BE Major Influences, Robert Young Says

May 7, 1999

FDA Spells Out Requirement For INDs For Cancer Drugs.

May 17, 2002

Heart Institute Withdraws Sponsorship Of Breast Cancer Prevention Trial

October 27, 1995